BioReNuva Announces Strategic Investment From Hallstar

Gunderson Dettmer represented client BioReNuva, an Austin-based biotechnology developer, in its newest investment from The Hallstar Company, a leading specialty chemical supplier for the beauty and personal care industry. BioReNuva uses biotechnology to turn common oils into ingredients called “glycolipids” that are safer to use for both users and the environment. The partnership will enable Hallstar to explore novel approaches in the biosynthesis space, leveraging BioReNuva's expertise and manufacturing capabilities.

In the announcement of the transaction, BioReNuva Founder Dennis Zlotnik said “My team and I have a strong affinity with Hallstar’s priorities, and we welcome this partnership. Strategic investors contribute to our company’s steady growth, and allow us to realize key goals when it comes to technical development, production capacity, and expansion into multiple verticals.”

The Gunderson deal team was led by Wes Watts.

Companies
BioReNuva
The Hallstar Company